Correlation Between Heart Rate Characteristic Index Score and Severity of Brain Injury in Neonates With Hypoxic-Ischemic Encephalopathy.

Adv Neonatal Care

Joe DiMaggio Children's Hospital, Hollywood Florida (Dr Kayton); Harvard Medical School, Boston, Massachusetts (Dr DeGrazia); Northeastern University, Boston, Massachusetts (Dr DeGrazia); Neonatal Intensive Care Unit, Boston Children's Hospital, Boston, Massachusetts (Dr DeGrazia); Division of Neonatology, Winnie Palmer Hospital for Women and Babies, Orlando, Florida (Ms Smith and Dr Perez); Clinical Nursing College of Nursing, The Ohio State University, Columbus, Ohio (Dr Sharpe); and Division of Neonatology, University of Florida, Gainesville (Dr Weiss).

Published: August 2020

Background: Hypoxic-ischemic encephalopathy (HIE) remains devastating for neonates despite widespread treatment with therapeutic hypothermia (TH). The heart rate characteristic (HRC) index score, a measure of heart rate variability, could prove useful in the management of neonates with HIE as new therapies emerge or when withdrawal-of-support decisions are being considered.

Purpose: The main purpose was to describe correlation between HRC index scores and brain magnetic resonance imaging (MRI) severity of injury for neonates with HIE.

Methods/analysis: Low/high HRC index scores retrieved at initiation of TH (baseline), 24, 48, 72, and 96 hours, brain MRI severity of injury, and National Institute of Child Health and Human Development Death/Disability and Death scores were collected and analyzed retrospectively. Independent t tests and linear regression were used to examine relationships for each outcome measure.

Results: Twenty-seven neonates were stratified into 2 groups: noninjury (n = 11) and injury (n = 16). Statistically significant relationships were observed. Strikingly, mean low HRC index score for the noninjury group ranged between 0.37 and 0.65 and was between 0.61 and 0.86 for the injury group. Mean high HRC index score for the noninjury group ranged between 0.66 and 1.02 and was between 1.04 and 1.41 for the injury group.

Implications For Practice: HRC index score may be a useful guide in the future management of neonates with HIE.

Implications For Research: This study established correlations between HRC index and MRI injury scores in neonates treated with TH. Further research is warranted to establish important relationships between brain injury and HRC index scores before this tool can be used clinically for this purpose.

Download full-text PDF

Source
http://dx.doi.org/10.1097/ANC.0000000000000686DOI Listing

Publication Analysis

Top Keywords

hrc score
16
heart rate
12
hrc scores
12
rate characteristic
8
injury
8
brain injury
8
injury neonates
8
hypoxic-ischemic encephalopathy
8
hrc
8
management neonates
8

Similar Publications

Background: Pelvic reconstruction after type I + II (or type I + II + III) internal hemipelvectomy with extensive ilium removal is a great challenge. In an attempt to anatomically reconstruct the hip rotation center (HRC) and achieve a low mechanical failure rate, a custom-made, 3D-printed prosthesis with a porous articular interface was developed. The aim of this study was to investigate the clinical outcomes of patients treated with this prosthesis.

View Article and Find Full Text PDF

 This article evaluates whether parameters derived from the gallium-68-labeled prostate-specific membrane antigen ( Ga-PSMA) positron emission tomography/computed tomography (PET/CT) imaging studies of primary prostate cancer (PCa) lesions were associated with Gleason score (GS), D'Amico risk class, Candiolo nomograms, and the metastatic status of the disease.  We retrospectively evaluated newly diagnosed PCa patients who underwent Ga-PSMA PET/CT before therapy. Age, baseline serum prostate-specific antigen (PSA), and metastatic status were recorded.

View Article and Find Full Text PDF

Introduction: Chronic pain (CP) affects 35.0%-51.3% of the UK population, with 67%-88% reporting sleep disturbances.

View Article and Find Full Text PDF

Prognostic impact of donor mitochondrial genomic variants in myelodysplastic neoplasms after stem-cell transplantation.

J Hematol Oncol

November 2024

Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, HRC 5860, Milwaukee, WI, 53226, USA.

Article Synopsis
  • Mitochondrial DNA (mtDNA) variants in donors significantly affect outcomes for MDS patients following allogeneic hematopoietic cell transplantation (allo-HCT), enhancing prognostic prediction.
  • Whole-genome sequencing of 494 donors revealed 1,825 mtDNA variants, with specific variants linked to posttransplant survival and relapse rates.
  • Incorporating donor mtDNA genotype, age, and HLA-matching into existing scoring systems can optimize donor selection, potentially improving transplant outcomes for MDS patients.
View Article and Find Full Text PDF

Risk stratification of acute pulmonary embolism.

Presse Med

September 2024

Ramón y Cajal Hospital (IRICYS), Respiratory Department, Madrid, Spain; Universidad de Alcalá (IRICYS), Medicine Department, Madrid, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain. Electronic address:

Risk stratification of patients with acute pulmonary embolism (PE) assists with the selection of appropriate initial therapy and treatment setting. Patients with acute symptomatic PE that present with arterial hypotension or shock have a high risk of death, and treatment guidelines recommend strong consideration of reperfusion in this setting. For haemodynamically stable patients with PE, the combination of a negative clinical prognostic score and the absence of computed tomography-assessed right ventricle enlargement may accurately identify those at low-risk of short-term complications after the diagnosis of PE, and such patients might benefit from an abbreviated hospital stay or outpatient therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!